TrialActa neuropsychiatrica2024

A double-blind, placebo-controlled, randomised withdrawal study of adjunctive brexpiprazole maintenance treatment for major depressive disorder.

Roger S McIntyre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.